Cancer remains a leading killer among medical causes of death worldwide. Scientists have been working for a long time on methods to identify and monitor the presence and spread of tumors in the body.

Background Effective decongestion is a key therapeutic goal during hospitalisation for acute heart failure (HF), but the ...

Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant plasma-cell disorder present in approximately 5% of the general population over the age of 50 years. MGUS is characterized ...

Real-world comparison: Neoadjuvant pembrolizumab (pembro-NACT) vs. dose-dense neoadjuvant chemotherapy (ddNACT) in early stage triple-negative breast cancer (TNBC). This is an ASCO Meeting Abstract ...

Tocilizumab is effective and safe for rheumatoid arthritis, with long-term studies supporting its use and comparable cardiovascular risk to tumor necrosis factor inhibitors. Real-world data indicate ...

Panelists discuss how ADA recommendations emphasize treating diabetes as part of overlapping conditions requiring cardiovascular and kidney protection, moving beyond just glycemic control to ...

Randomized controlled trials remain the most effective tool in the pharmaceutical industry’s evidence-generation toolkit. They are crucial for demonstrating novel drugs' safety and efficacy, assessing ...

In collaboration with Merck, a global biopharmaceutical company, we want to spread the word about the importance of clinical trials. In the video above, Dr. Adrelia Allen, Executive Director of ...